Stellate Ganglion Block

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
University of Minnesota
Study ID
NCT06271707
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

  • Esophagectomy
  • Lobectomy
  • Pneumonectomy

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • 0.5% bupivacaine — DRUG
    an ultrasound guided left stellate ganglion block with 5 mL of 0.5% bupivacaine
  • Saline — OTHER
    an ultrasound guided left stellate ganglion block with 5 mL of saline

Study Details

The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.

Key Dates

Start date
May 19, 2025
Status verified
Aug 2025
Primary completion
Apr 15, 2027
Completion
Jul 15, 2027

Study Design

Enrollment
48 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Group 1
    ultrasound with bupivacaine
  • Sham Comparator: Group 2
    Ultrasound with saline

Primary Outcome Measure

an ultrasound guided left stellate ganglion block with 5 mL of saline. [ Time Frame: 168 hours after surgery ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MinnesotaMinneapolisMinnesota55455
Candace Nelson
[email protected]
612-626-2465

Find similar trials in Minneapolis, MN

By research site
University of Minnesota· Minneapolis, MN

Related Studies